Table 2.
Predictor | Outcome | HR | Multivariable-adjusted 95% CI | P |
---|---|---|---|---|
BMI | Incident HFpEF | 1.34* | (1.24 – 1.45) | <0.0001 |
Incident HFrEF | 1.18 | (1.10 – 1.27) | <0.0001 | |
WC | Incident HFpEF | 1.32 | (1.22 – 1.44) | <0.0001 |
Incident HFrEF | 1.19 | (1.10 – 1.29) | <0.0001 | |
WHR | Incident HFpEF | 1.19 | (1.10 – 1.29) | <0.0001 |
Incident HFrEF | 1.14 | (1.06 – 1.22) | 0.001 | |
HOMA-IR | Incident HFpEF | 1.20* | (1.05 – 1.37) | 0.006 |
Incident HFrEF | 0.99 | (0.88 – 1.11) | 0.81 | |
TG/HDL ratio | Incident HFpEF | 1.06 | (0.96 – 1.17) | 0.27 |
Incident HFrEF | 1.13 | (1.04 – 1.23) | 0.003 | |
Fasting glucose | Incident HFpEF | 1.15 | (1.08 – 1.23) | <0.0001 |
Incident HFrEF | 1.07 | (0.99 – 1.16) | 0.08 | |
SBP | Incident HFpEF | 1.20 | (1.11 – 1.20) | <0.0001 |
Incident HFrEF | 1.19 | (1.11 – 1.27) | <0.0001 |
P for difference <0.05 using Lunn-McNeil method to compare HR for HFpEF versus HFrEF
BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; HOMA-IR, homeostatic model assessment of insulin resistance; TG/HDL ratio, triglyceride-to-high density lipoprotein ratio; SBP, systolic blood pressure.
Hazard ratio per 1- standard deviation increase in continuous predictor
HOMA-IR, triglycerides, and TG/HDL ratio were log-transformed
The multivariable model was adjusted for age, sex, SBP (except SBP analyses), hypertension treatment, diabetes, smoking, prevalent myocardial infarction, TC, HDL (except TG/HDL analyses), left bundle branch block or left ventricular hypertrophy. HOMA-IR analyses excluded participants with diabetes.